Trademark: 97253196
Word
ENLIGHT-LN
Status
Pending
Status Code
819
Status Date
Wednesday, March 13, 2024
Serial Number
97253196
Mark Type
4000
Filing Date
Friday, February 4, 2022
Published for Opposition
Tuesday, December 27, 2022

Trademark Owner History
Aurinia Pharmaceuticals Inc. - Owner At Publication

Classifications
42 Medical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis
ENLIGHTEN

Trademark Events
Mar 14, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 13, 2024
Allowed Principal Register - Sou Accepted
Mar 12, 2024
Statement Of Use Processing Complete
Feb 21, 2024
Use Amendment Filed
Mar 11, 2024
Case Assigned To Intent To Use Paralegal
Feb 21, 2024
Teas Statement Of Use Received
Aug 31, 2023
Assigned To Examiner
Aug 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 21, 2023
Sou Extension 1 Granted
Aug 21, 2023
Sou Extension 1 Filed
Aug 21, 2023
Sou Teas Extension Received
Feb 21, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 27, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2022
Published For Opposition
Dec 7, 2022
Notification Of Notice Of Publication E-Mailed
Nov 22, 2022
Approved For Pub - Principal Register
Nov 17, 2022
Assigned To Examiner
Feb 9, 2022
New Application Office Supplied Data Entered
Feb 8, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24